News from cytosorbents corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 24, 2021, 07:08 ET CytoSorbents to Present at the Cowen 41st Annual Health Care Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Feb 18, 2021, 07:08 ET CytoSorbents 2021: Leadership and Growth in the "New Normal"

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Feb 16, 2021, 07:08 ET CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Feb 04, 2021, 07:08 ET National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Jan 21, 2021, 07:08 ET CytoSorbents Appoints David D. Cox, PhD, MBA as Vice President - Global Regulatory Affairs

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Jan 19, 2021, 07:08 ET CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Jan 12, 2021, 07:00 ET Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Jan 12, 2021, 06:58 ET CytoSorbents Reports Preliminary Fourth Quarter and Full Year 2020 Revenue

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Jan 11, 2021, 06:00 ET CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Jan 04, 2021, 06:30 ET Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Dec 17, 2020, 07:08 ET CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and Marketing

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Dec 10, 2020, 07:00 ET CytoSorbents Pays Off $15M Term Loans and Establishes New Undrawn $15M Loan Commitment with Bridge Bank

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Dec 09, 2020, 06:45 ET Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock Study

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Dec 02, 2020, 07:08 ET CytoSorbents Launches International Campaign to Raise $100,000 for the Global Humanitarian Organization, CARE

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader that is commercializing its CytoSorb® blood purification technology to...

Nov 25, 2020, 07:08 ET CytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 Patients

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Nov 23, 2020, 07:00 ET CytoSorbents to Present at the Piper Sandler 32nd Annual Healthcare Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Nov 12, 2020, 02:00 ET CytoSorbents to Present at the Jefferies Virtual London Healthcare Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Nov 04, 2020, 16:15 ET CytoSorbents Reports Record Third Quarter 2020 Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly...

Oct 21, 2020, 07:08 ET CytoSorbents to Report Q3 2020 Operating and Financial Results

CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly...

Oct 14, 2020, 07:00 ET CytoSorbents and Aferetica Announce European Union Approval of the PerLife™ System and ECOS-300CY™ PerSorb™ Cartridge for Combined Perfusion and Purification of Solid Organs Dedicated to Transplant

CytoSorbents Corporation (NASDAQ: CTSO; USA) and Aferetica srl (Italy), two pioneers in intensive care immunotherapy and blood purification, announce ...

Oct 09, 2020, 07:08 ET The U.S. Department of Defense Awards $1.1 Million to CytoSorbents to Optimize Development of HemoDefend-BGA™ for Life-saving Universal Plasma

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader specializing in blood purification, announced today that the U.S. Army...

Sep 21, 2020, 07:08 ET CytoSorb Achieves Registration in Brazil and Is Now Commercially Available To Treat Cytokine Storm in COVID-19 Infection and Other Conditions

CytoSorbents Corporation (Nasdaq: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Sep 11, 2020, 08:00 ET CytoSorbents Highlights CytoSorb Use in Sepsis Patients During Sepsis Awareness Month and World Sepsis Day 2020

CytoSorbents Corporation (Nasdaq: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Sep 08, 2020, 07:08 ET CytoSorbents Announces the "CytoSorb Therapy in COVID-19 ICU Patients" (CTC) Registry Is Actively Enrolling

CytoSorbents Corporation (Nasdaq: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...

Aug 17, 2020, 07:08 ET CytoSorbents Partners with InvoSurg and Surgical Partners to Commercialize CytoSorb® in the U.S. Northeast, Mid-Atlantic, and Florida under FDA Emergency Use Authorization for COVID-19

CytoSorbents Corporation (NASDAQ: CTSO) has entered into separate agreements with InvoSurg Inc. and Surgical Partners to commercialize CytoSorb®...